Clarivate Plc

Clarivate Plc engages in the provision of global information, analytics and workflow solutions. It operates through the Science and Intellectual Property segments. The Science segment is composed of the academia and government, and life science and healthcare product lines. The Intellectual Property segment includes the patent, trademark, domain, and IP management product lines. The company was founded in 1864 and is headquartered in London, the United Kingdom.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Clarivate Plc reports strong Q4 earnings, eyes growth opportunities

Clarivate Plc delivered strong financial results in Q4 2022, driven by the successful ProQuest acquisition and solid organic growth across segments. The company is focused on achieving higher organic growth, reducing leverage, and leveraging culture for success.
While facing macroeconomic challenges and pricing pressures, Clarivate Plc is confident in its strategic plans and capital structure initiatives. Opportunities lie in leveraging AI, enhancing product offerings, and capitalizing on the positive pricing environment.
Navigating challenges such as tough comps, managing inflation impact, and balancing quarterly patterns will be crucial. The company's proactive approach to growth, focus on customer value, and upcoming Investor Day position it well for future success.

Clarivate Plc reports stable Q1 performance amidst growth challenges

Clarivate Plc's Q1 2023 performance showcased stable revenue, strong margins, and strategic financial initiatives despite challenges in net income and organic growth cadence.
The company's strengths lie in market engagement, AI innovation, maintained outlook, and effective pricing strategies, positioning it for continued growth.
Challenges include earnings volatility, execution hurdles in growth projections, and longer-term segment revenue impacts, necessitating strategic planning and operational focus.
Opportunities in AI applications, cash flow utilization, revenue drivers, and segment progress offer avenues for revenue diversification, growth investments, and market expansion.

Clarivate Plc faces revenue challenges but drives growth through innovation

Clarivate Plc's Q2 performance saw challenges in key segments impacting revenue and outlook, despite operational improvements and strategic initiatives.
While facing hurdles in patent annuities and commercialization subsegment growth, the company focuses on sustainability, product innovations, and customer-centric strategies for future growth.
Detailed financial results and revised guidance reflect the company's proactive approach to address challenges and capitalize on opportunities for sustainable growth.
With a pivot around three segments and emphasis on higher-touch sales, Clarivate aims to navigate challenges, leverage opportunities, and drive revenue growth in the evolving market landscape.

Clarivate Plc reports Q3 growth, tackles challenges, eyes tech acquisitions

Clarivate Plc's Q3 performance showed growth in key segments despite challenges in IP and LS&H businesses.
Opportunities lie in technology acquisitions, analytic platforms, and direct sales to pharma companies.
Management remains optimistic about quarterly results and progress, focusing on enhancing growth strategies.

Clarivate Plc reports solid Q4 performance amidst sector challenges

Clarivate Plc's Q4 2023 performance reflects progress in key segments and a strategic focus on organic growth and operational efficiencies.
While facing challenges in the A&G segment and market conservatism, the company is leveraging strengths in Life Sciences investments and pricing strategies.
Opportunities lie in growth acceleration through new offerings, improved organic growth, and renewed optimism in the life sciences sector.

Clarivate Plc reports Q1 revenue growth, eyes segment expansion

Clarivate Plc's Q1 performance showed promising organic revenue growth and steady renewal rates, with a focus on future investments for growth.
While facing financial challenges and neutral market conditions, the company sees opportunities in segment growth and real-world data solutions.
Overall, Clarivate remains on track with full-year guidance, aiming for 1% organic growth and focusing on driving subscription business growth.

Clarivate Plc reports mixed Q2 results, focuses on growth strategies

Clarivate Plc reported mixed financial results in Q2 2024, with slight revenue growth but challenges in certain segments.
Management emphasized resilience in adjusted EPS and operating cash flow, focusing on growth plans and operational improvements.
Analysts raised concerns about project delays and segment performance, but opportunities in product innovation and revenue growth were highlighted.
The company aims to drive subscription revenue growth through upcoming product releases and investment in business.

Clarivate Plc faces revenue decline in Q3 but focuses on growth strategies

Clarivate Plc's Q3 2024 earnings call highlighted challenges in revenue decline and net loss, with a focus on repositioning and value creation. The company is implementing a Value Creation Plan to optimize its business model and drive sustainable growth. Opportunities exist in improving sales execution, product innovation, and aligning the portfolio for enhanced profitability.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Clarivate Plc engages in the provision of global information, analytics, and workflow solutions. It operates through the following segments: Academia and Government (A&G), Intellectual Property (IP), and Life Sciences and Healthcare (LS&H). The A&G segment involves the provision of research and analytics, content aggregation, and workflow software solutions using artificial intelligence. The IP segment includes the maintenance, intelligence, and management solutions. The LS&H focuses on solutions for research and development, regulatory and safety, and commercialization. The company was founded in 1864 and is headquartered in London, the United Kingdom.

LONDON , July 26, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that in the 2023 release of the Journal Citation Reports all Web of Science Core Collection™ journals will receive a Journal Impact Factor (JIF)™. This means expanding the JIF from Science Citation Index Expanded (SCIE)™ and Social Science Citation Index (SSCI)™ to include journals from the Arts and Humanities Citation Index (AHCI)™ and the multidisciplinary Emerging Sources Citation Index (ESCI)™.

Clarivate announces changes to the 2023 Journal Citation Reports All Web of Science Core Collection journals, including arts and humanities will have Journal Impact Factors

MarkMonitor becomes the first and only foreign-owned domain name registrar licensed in Mainland China to offer .com, .cn and .net  Top Level Domains LONDON , July 21, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced it is the first and only licensed foreign-owned domain name registrar in Mainland China to offer a wide range of Top Level Domains including .com, .net, .cn, .中国, to companies hosting website content locally.

Clarivate Awarded Expanded License for Domain Service in Mainland China

Special report on aging investigates the latest science, key biological drivers and companies driving the development of potential "Fountain of Youth" candidate drugs LONDON , July 20, 2022 /PRNewswire/ -- BioWorld published by Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release of a new report, Extending the Human Lifespan, which examines the science around extending our time on earth alongside our quality of life. The report provides an in-depth analysis of the latest science, the key biological drivers that can be targeted pharmacologically and the companies developing these potential "Fountain of Youth" candidate drugs.

BioWorld by Clarivate Explores the Concept of Extending Human Lifespan in New Report

LONDON , July 11, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that Jerre Stead, Executive Chair and Chief Executive Officer, is retiring from his CEO role effective September 1, 2022, but will continue as Non-Executive Chair of the Board of Directors. During Mr.

Clarivate Announces Retirement of Chief Executive Officer Jerre Stead and Appointment of Jonathan Gear as New CEO

LONDON , July 7, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today it will report its financial results for the second quarter 2022 before the market opens on Tuesday, August 9. The press release and earnings supplement, with accompanying financial information, will be posted on the Clarivate investor website at https://ir.clarivate.com.

Clarivate to Report Second Quarter 2022 Results on August 9, 2022

Using the Web of Science to Identify and Promote Research Excellence LONDON , July 6, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, has been selected to provide citation data for the Excellence in Research for Australia (ERA) 2023, the country's national university research evaluation framework. In doing so, Clarivate will help the Australian Research Council to identify research excellence by discipline, across the entire Australian university research sector.

Clarivate to Exclusively Provide Citation Data to the Australian Research Council for Excellence in Research Australia 2023

From TikTok to Comirnaty - Software, media, fintech and finance; luxury, fashion, sports; and pharmaceutical brands comprise nearly half the list with 15 brands each LONDON , June 30, 2022 /PRNewswire/ -- Clarivate Plc  (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released the first ever Top   100 New Brands  report. The report draws on data from more than 20 million new trademark applications worldwide to identify new brands which have surged into the public sphere in the last two years.

Clarivate Top 100 New Brands Report Reveals Trends and Hotspots in Rapidly Evolving Global Brand Landscape

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether certain directors of Clarivate Plc (“Clarivate”) (NYSE: CLVT) breached their fiduciary duties to Clarivate and its shareholders. If you are a Clarivate shareholder, you may contact attorney Joe Pettigrew for additional information toll-free at 844-818-6982 or jpettigrew@scott-scott.com. Scott+Scott is investigating whether Clariva

CLARIVATE INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Clarivate's Plc's Directors for Breach of Fiduciary Duties – CLVT

Continued increase in citation impact for journals publishing COVID-19 research LONDON , June 28, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released the 2022 update to its annual Journal Citation Reports (JCR)™. The annual JCR release enables the research community to evaluate the world's high-quality academic journals using a range of indicators, descriptive data and visualizations.

Clarivate Names World's Leading Journals with the 2022 Journal Citation Reports

LONDON , June 1, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that Jerre Stead, Executive Chair and Chief Executive Officer, and Jonathan Collins, Executive Vice President and Chief Financial Officer, will present at the following investor conferences in June 2022. Stifel 2022 Cross Sector Insight Conference on Tuesday, June 7, 2022 at 9:10 am Eastern Time.

Clarivate to Present at Upcoming Investor Conferences in June 2022

Revealing impact across all 17 United Nations Sustainable Development Goals with 46% of revenues attributable to SDGs LONDON , May 24, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today published its second annual sustainability report. The interactive report outlines the progress Clarivate made in 2021 in the areas of Environment, Social and Governance (ESG), and presents ambitious long-term goals for the business.

Clarivate Annual Sustainability Report Highlights 2021 Milestones, Establishes Sustainability as Strategic Business Imperative

LONDON , May 11, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT; CLVT PR A), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that its board of directors declared a quarterly dividend of $1.3125 per share on its 5.25% Series A Mandatory Convertible Preferred Shares, payable in cash on June 1, 2022 to shareholders of record at the close of business on May 13, 2022.  Forward-Looking Statements This communication contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995.

Clarivate Declares Dividend on Mandatory Convertible Preferred Stock

Clarivate Plc (NYSE:CLVT ) Q1 2022 Earnings Conference Call May 9, 2022 9:00 AM ET Company Participants Mark Donohue - Head of Investor Relations Jerre Stead - Executive Chair & Chief Executive Officer Jonathan Collins - Chief Financial Officer Gordon Samson - Chief Product Officer Steen Lomholt-Thomsen - Chief Revenue Officer Conference Call Participants Toni Kaplan - Morgan Stanley George Tong - Goldman Sachs Andrew Nicholas - William Blair Ashish Sabadra - RBC Capital Markets Hamzah Mazari - Jefferies Shlomo Rosenbaum - Stifel Pete Christiansen - Citi Operator Hello and welcome to today's Clarivate First Quarter 2022 Earnings Conference Call. My name is Bailey and I will be your moderator for today's call.

Clarivate Plc (CLVT) CEO Jerre Stead on Q1 2022 Results - Earnings Call Transcript

Clarivate PLC (CLVT) delivered earnings and revenue surprises of 10.53% and 2.05%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Clarivate PLC (CLVT) Q1 Earnings Top Estimates

— Reaffirms 2022 Outlook — LONDON , May 9, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in providing trusted information and insights to accelerate the pace of innovation, today reported results for the first quarter ended March 31, 2022. First Quarter 2022 Financial Highlights Revenues of $662.2 million increased 54.6%, and 57.6% at constant currency Organic revenues(1) increased 4.4% at constant currency Net income(2) attributable to ordinary shares of $50.8 million increased $106.8 million; Net loss per diluted share of $0.06 improved by $0.11 Adjusted Net Income(1) of $155.1 million increased 75.4%; Adjusted Income per diluted share(1) of $0.21 increased 50.0% or $0.07 Adjusted EBITDA(1) of $262.3 million increased 59.2% and Adjusted EBITDA Margin(1) of 39.6% increased 140 basis points "Clarivate had a good start to the year with organic revenue growth of 4.4% and strong profit conversion," said Jerre Stead, Executive Chair and CEO.

Clarivate Reports First Quarter 2022 Results

LONDON , April 14, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today it will report its financial results for the first quarter 2022 before the market opens on Monday, May 9. The press release and earnings supplement, with accompanying financial information, will be posted on the Clarivate investor website at https://ir.clarivate.com.

Clarivate to Report First Quarter 2022 Results on May 9, 2022

Winners include Liberty Hospital, four Ardent Health Services hospitals, University of Iowa Hospitals & Clinics and Novant Health LONDON , April 4, 2022 /PRNewswire/ -- Today, Clarivate Healthcare Business InsightsTM  , a part of Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced the 2021 winners of its annual Revenue Cycle Awards. In its 10th year, the Revenue Cycle Awards recognizes healthcare organizations for achieving outstanding performance on revenue cycle KPIs, based on data from their most recent and preceding full fiscal years.

Clarivate Healthcare Business Insights Announces 2021 Revenue Cycle Awards Recipients

LONDON , March 30, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today launches a new Global Research Report from the Institute for Scientific Information which outlines the research landscape of eleven countries across Central Europe – identifying rapidly maturing research networks. Central Europe: A profile of the region and its place in the European research network  highlights the current research output of the countries that acceded to the European Union post-2000 - Bulgaria, Croatia, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Romania, Slovakia and Slovenia.

Clarivate Launches New Report on the Research Profile of Central Europe

NEW YORK--(BUSINESS WIRE)-- #Clarivate--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Clarivate Plc (NYSE: CLVT) on behalf of long-term stockholders following a class action complaint that was filed against Clarivate on January 24, 2022 with a Class Period from November 10, 2020 to February 2, 2022. Our investigation concerns whether the board of directors of Clarivate have breached their fiduciary duties to the company. The c

CLARIVATE ALERT: Bragar Eagel & Squire, P.C. is Investigating Clarivate Plc on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Support to accelerate the pace of research and discovery   LONDON , March 28, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today launched a package of valuable Clarivate resources of software tools, information and insights to support displaced researchers from Ukraine. The resource center also contains news and content to help raise the profile, knowledge and understanding of Ukraine across the world.

Clarivate Commits to #StandWithUkraine with Launch of Resource Center for Displaced Researchers

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Clarivate To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - March 27, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Clarivate Plc ("Clarivate" or the "Company") (NYSE: CLVT) (NYSE: CLVT-PA) and reminds investors of the March 25, 2022 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you suffered losses exceeding $100,000 investing in Clarivate (a) stock...

Clarivate Update

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Clarivate To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - March 25, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Clarivate Plc ("Clarivate" or the "Company") (NYSE: CLVT) (NYSE: CLVT.PA) and reminds investors of the March 25, 2022 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you suffered losses exceeding $100,000 investing in Clarivate (a) stock...

Clarivate Class Action Reminder

NEW YORK, March 25, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Clarivate Plc (NYSE: CLVT). To receive updates on the lawsuit, fill out the form: https://claimyourloss.com/securities/clarivate-plc-loss-submission-form/?id=25103&from=4 The lawsuit seeks to recover losses for shareholders who purchased Clarivate between November 10, 2020 and February 2, 2022.

CLVT SHAREHOLDER ALERT: Jakubowitz Law Reminds Clarivate Shareholders Of A Lead Plaintiff Deadline Of March 25, 2022

RADNOR, Pa. , March 24, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Clarivate Plc ("Clarivate") (NYSE: CLVT; CLVT-PA).

Final Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Filed Against Clarivate Plc (CLVT)

NEW YORK, March 24, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Clarivate Plc ("Clarivate" or the "Company") (NYSE: CLVT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Clarivate investors who were adversely affected by alleged securities fraud between November 10, 2020 and February 2, 2022.

News for Clarivate Plc Stock (CLVT)